Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain, Postoperative 12Brain Neoplasms 8Breast Neoplasms 5Agnosia 4Thyroid Neoplasms 3Stomach Neoplasms 3Lung Neoplasms 3Emergence Delirium 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Pain 2Inflammation 2Dexmedetomidine 2Delirium 2Chronic Pain 2Thrombosis 1Supratentorial Neoplasms 1Sigmoid Neoplasms 1Sedation 1Sarcoma 1Retinoblastoma 1Rectal Neoplasms 1Prostatic Hyperplasia 1Postoperative Nausea and Vomiting 1Pneumoperitoneum 1Pheochromocytoma 1Opioid Consumption, Postoperative 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Saline Solution 2Mannitol 2Ropivacaine 1Propofol 1Long-Term Synaptic Depression 1HES 130-0.4 1Dexmedetomidine 1Desflurane 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Supratentorial Neoplasms × Dexmedetomidine × Clear all
NCT02007798 2014-01-14

Small-dose Dexmedetomidine Effects on Recovery Profiles of Supratentorial Tumors Patients From General Anesthesia

China Medical University, China

Phase NA Unknown
150 enrolled
CNS

Brain Neoplasms, Supratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡